<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154858">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02089191</url>
  </required_header>
  <id_info>
    <org_study_id>M-14-006</org_study_id>
    <nct_id>NCT02089191</nct_id>
  </id_info>
  <brief_title>Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses</brief_title>
  <official_title>Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate tear film stability of DAILIES® AquaComfort Plus®
      (DACP) compared to MyDay® after 12 hours of lens wear.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Time to 15% Distortion After 12 Hours</measure>
    <time_frame>Hour 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time from first eye opening to 15% distortion of the ring mires projected onto the tear film.  The right eye will be used for the analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Speed of Tear Film Break Up at 15 Seconds After 12 Hours</measure>
    <time_frame>Hour 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>The slope of the regression line (distorted areas vs. time) will be calculated. The right eye will be used for the analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>DACP, then MyDay</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nelfilcon A contact lenses worn first, with stenfilcon A contact lenses worn second.  Each product worn in both eyes for 1 day, up to 12 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MyDay, then DACP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Stenfilcon A contact lenses worn first, with nelfilcon A contact lenses worn second.  Each product worn in both eyes for 1 day, up to 12 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nelfilcon A contact lenses</intervention_name>
    <arm_group_label>DACP, then MyDay</arm_group_label>
    <arm_group_label>MyDay, then DACP</arm_group_label>
    <other_name>DAILIES® AquaComfort Plus®</other_name>
    <other_name>DACP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stenfilcon A contact lenses</intervention_name>
    <arm_group_label>DACP, then MyDay</arm_group_label>
    <arm_group_label>MyDay, then DACP</arm_group_label>
    <other_name>MyDay®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must sign an Informed Consent form;

          -  Adapted, current soft contact lens wearer;

          -  Required contact lens prescription within the power range specified in the protocol
             (+6.00 to -10.00 diopters (D));

          -  Cylinder ≤ -1.00 D in both eyes at Visit 1;

          -  Vision correctable to 0.1 logarithm of the Minimum Angle of Resolution (logMAR) or
             better in each eye at distance with pre-study lenses at Visit 1;

          -  Willing to wear study lenses up to 12 hours and attend all study visits;

          -  Able to be successfully fitted with study lenses;

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Any ocular infection, inflammation, abnormality, or active disease that would
             contraindicate contact lens wear;

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated, as determined by the Investigator;

          -  Use of artificial tears and rewetting drops during the study;

          -  Monocular (only 1 eye with functional vision) or fit with only 1 lens;

          -  Any abnormal ocular condition observed during Visit 1;

          -  History of herpetic keratitis, ocular surgery, or irregular cornea;

          -  Pregnant or lactating;

          -  Participation in any clinical study within 30 days of Visit 1;

          -  Current MyDay® or DAILIES® AquaComfort Plus® lens wearer;

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa L. Zoota, MPH, CCRA</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 30, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DACP</keyword>
  <keyword>DAILIES® AquaComfort Plus</keyword>
  <keyword>Tear film stability</keyword>
  <keyword>NIK-BUT</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
